Short description
Ocular Therapeutix develops and commercializes ophthalmic therapeutic products by using hydrogel technology.
Description
Ocular Therapeutix, Inc. engages in the development and commercialization of ophthalmic therapeutic products using its proprietary hydrogel technology to address unmet or underserved needs in ophthalmology. Its products include ReSure Adherent Ocular Bandage, a synthetic ocular bandage for ophthalmic surgery; ReSure Sealant, a synthetic and biocompatible hydrogel that creates a temporary, soft, and lubricious surface barrier to protect clear corneal incisions in the immediate post-operative period; and prostaglandin analog punctum plugs that are hydrogel-based punctum plug depots to deliver prostaglandin analogs to treat glaucoma.
Last funding
Nopepepe
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Bedford, Massachusetts, United States, North America
Founded on
January 1, 2006
Exited on
July 28, 2014
Went public on
July 28, 2014
Stock symbol
OCUL
Non-profit?
No
Acquired?
No
Employees count
251-500
Revenue range
$7890 - 12340
Sign in for full access
Investors
Nopepepe, No Way, Blurry Noaccess, Noaccess, Noaccess, Nopepepe, Uh Ohhhh, Noaccess, Blurry Noaccess, Noaccess, Noway Youcantaccess, No Way, Nopepepe, Nopepepe, Noway Youcantaccess, Noaccessforu, Noaccess
Sign in for full access
Founders
Amarpreet Sawhney, Farhad Khosravi